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ABSTRACT 
Astrocytes, a key homeostatic cell type in the mammalian central nervous system (CNS), have 
various functions in health and diseases. In neurotrauma, stroke, epilepsy or neurodegenerative 
diseases, astrocytes become reactive, which is known as reactive gliosis. Two characteristic 
hallmarks of reactive gliosis are hypertrophy of astrocyte processes and up-regulation of the 
intermediate filament (also known as nanofilament) proteins GFAP, vimentin, nestin and synemin. 
Reactive astrocytes have a neuroprotective role in the acute stage of CNS pathologies, by handling 
the acute stress, limiting the tissue damage and restoring the homeostasis of the CNS, but 
persisting reactive gliosis in some situations can become maladaptive and lead to the inhibition of 
neural plasticity and other regenerative responses. Animal studies suggested that some reactive 
astrocytes can act as neural stem cells after injury. 
We hypothesized that some reactive astrocytes within the epileptic foci of patients with epilepsy 
have neural progenitor cell properties. We studied material from surgical resections from patients 
with pharmacologically intractable epilepsy after we first established protocols for dissociating 
such tissue into single live cells. We showed that cells with neural progenitor cell properties exist 
in the epileptic cortex outside the well-established adult neurogenic regions (i.e. outside the 
subventricular zone and the hippocampal dentate gyrus), and demonstrated that these neural 
progenitor cells are not glutamate aspartate transporter (GLAST) expressing astrocytes. 
Modulation of the astrocyte nanofilament system was proposed as a potential therapeutic strategy 
in some CNS pathologies. To assess the role of vimentin phosphorylation in neurogenesis, we 
used VIMSA/SA mice, in which the serine sites in the vimentin molecule that are phosphorylated 
during mitosis had been mutated, which show cytokinetic failure in fibroblasts and lens epithelial 
cells. We found that mutation of the serine sites phosphorylated in vimentin during mitosis leads 
to increased neuronal differentiation of neural progenitor cells, and suggest that this is a neural 
progenitor cell intrinsic phenotype. 
We studied three drug candidates that could potentially decrease the expression of GFAP and the 
other astrocyte nanofilament proteins, and assessed their effect on neurosupportive properties and 
resilience of astrocytes to oxygen and glucose deprivation (OGD), an in vitro model for brain 
ischemia. We found that two of them increased survival of neurons co-cultured with astrocytes, 
which makes them potential candidates for attenuation of reactive gliosis in vivo. 
 
Key words: astrocytes, intermediate filaments, reactive gliosis, GFAP, GLAST, vimentin, neural 
progenitor cells, neurogenesis, Bioactive3D culture system 
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1. INTRODUCTION 
1.1 Astrocytes and reactive gliosis 
1.1.1 The function of astrocytes in healthy brain 
The major cellular players within the mammalian central nervous system (CNS) are 
neurons and glial cells. Neurons are defined as electrically excitable cells, which fire 
action potentials that propagate to axonal terminals and initiate synaptic transmission. 
Glial cells are defined as electrically non-excitable cells, which are optimized for 
housekeeping, control and neural tissue protection (Pekny et al., 2016). Glial cells are 
composed of macroglia, e.g. astrocytes, oligodendrocytes, NG2 glia, and microglia. 
Astrocytes, also known as astroglial cells, are the most abundant cell type in the 
mammalian CNS. In the past, astrocytes were only believed to provide structural and 
nutritional support for the neurons, and this neuron-centered view has changed during the 
past 30 years. Astrocytes are now receiving increasing attention from neuroscientists and 
neurologists.  
 
The importance of astrocytes in the maintenance of the CNS homeostasis, nutrition of 
neuronal cells and neurotransmitter recycling has long been known, as reviewed in 
(Khakh and Sofroniew, 2015; Parpura et al., 2012; Pekny et al., 2016; Verkhratsky et al., 
2014). More recently, astrocytes were shown to control many other functional aspects of 
the CNS, both in health and disease. These range from the control of blood flow 
(Mulligan and MacVicar, 2004; Zonta et al., 2003), induction, elimination and functional 
control of neuronal synapses (Carmona et al., 2009; Christopherson et al., 2005; Chung 
et al., 2013; Sultan et al., 2015; Ullian et al., 2001; Yang et al., 2016), to the role in neural 
plasticity responses and regeneration processes [(Cho et al., 2005; Pekny et al., 2016; 
Widestrand et al., 2007);Fig 1]. 
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1.1.2 Reactive astrocytes in diseased brain 
Upon CNS injury, such as neurotrauma, stroke, epilepsy or neurodegenerative diseases, 
astrocytes become reactive, which is known as reactive gliosis (Pekny and Pekna, 2014; 
Pekny et al., 2016). Reactive gliosis is accompanied by various morphological and 
functional changes of astrocytes (Eddleston and Mucke, 1993; Sofroniew, 2009; 
Sofroniew and Vinters, 2010). The two cellular hallmarks of reactive gliosis are 
hypertrophy of astrocyte processes and up-regulation of the intermediate filament 
proteins GFAP, vimentin, nestin and synemin. In the acute stage of the injury, reactive 
gliosis has a protective role by handling the acute stress, limiting the tissue damage and 
restoring the CNS homeostasis. However, persisting reactive gliosis in some situations 
can become maladaptive and lead to inhibition of neural plasticity and other regenerative 
responses [for the review, see (Pekny and Pekna, 2014; Pekny and Pekna, 2016; Pekny 
et al., 2016); Fig 1] 
 
Fig 1. Astrocyte functions in health and disease, adapted from (Pekny and Pekna, 2016) 
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1.2 The intermediate filament system 
1.2.1 The intermediate filaments 
The cytoskeleton is composed of actin filaments, intermediate filaments (also known as 
nanofilaments), and microtubules. Actin filaments are the thinnest cytoskeletal elements 
of a diameter at around 7 nm, and are important e.g. for cell motility. Microtubules are 
the thickest cytoskeletal filaments of a diameter at around 25 nm with a tubular structure, 
and are important e.g. for intracellular transport and cell division. The diameter of 
intermediate filaments is around 10 nm, hence the name “intermediate”. Unlike actin 
filaments and microtubules that are expressed in almost all eukaryote cells, the expression 
of individual intermediate filament proteins is highly cell-type specific (Herrmann et al., 
2007; Wickstead and Gull, 2011).  
 
In humans, intermediate filament proteins are encoded by at least 65 genes, giving rise to 
a large protein family (Herrmann et al., 2007). All intermediate filament protein 
molecules consist of a head, rod and tail domain. The α-helical rod domain is highly 
conserved, while the N-terminal head and C-terminal tail domains show large variations 
between intermediate filament proteins. Depending on the amino acid sequence and 
protein structure, the intermediate filament proteins are divided into six subclasses 
[(Eriksson et al., 2009; Guerette et al., 2007; Herrmann et al., 2007; Hyder et al., 2008); 
Table 1].  
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Table 1. The major intermediate filament proteins and examples of their tissue specificity  
 
Type Protein Site of expression 
I Acidic keratins Epithelial cells 
II Neutral or basic keratins Epithelial cells 
III Vimentin 
Glial fibrillary acidic protein (GFAP) 
Desmin 
Peripherin 
Fibroblasts, white blood cells, glial cells 
Astrocytes 
Muscle  
Peripheral neurons 
IV Neurofilament proteins  Neurons 
V Nuclear lamins Nuclear lamina of all cell types 
VI Nestin 
Synemin 
Neural stem cells, astrocytes 
Muscle, astrocytes 
 
1.2.2 Intermediate filaments and reactive astrocytes 
Four intermediate filament proteins are expressed in astrocytes: GFAP, vimentin, nestin 
and synemin. The expression of these four intermediate filament proteins in astrocytes 
depends on the type of astrocytes, developmental stage and the degree of astrocyte 
activation. Nestin and synemin are expressed in astrocyte precursors and in immature 
astrocytes (Lendahl et al., 1990; Pekny et al., 2014; Sultana et al., 2000). As astrocytes 
mature, GFAP expression increases while vimentin expression decreases, and nestin 
expression disappears (Bignami et al., 1982; Lendahl et al., 1990). In mature non-reactive 
astrocytes, GFAP and vimentin are the building blocks of the intermediate filament 
bundles. In neurotrauma, stroke, epilepsy or neurodegenerative diseases, astrocytes 
become reactive and up-regulate all the four intermediate filament proteins (Eddleston 
and Mucke, 1993; Eng and Ghirnikar, 1994; Jing et al., 2007; Lin et al., 1995).  
 
We and others previously demonstrated that mice carrying null mutations in genes 
encoding GFAP and vimentin (GFAP–/–Vim–/– mice), have astrocytes devoid of astrocyte 
intermediate filaments (Eliasson et al., 1999; Pekny et al., 1999), and exhibit better 
posttraumatic regeneration of neuronal synapses and axons (Cho et al., 2005; 
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Wilhelmsson et al., 2004), improved functional recovery after spinal cord injury (Menet 
et al., 2003), reduced photoreceptor degeneration in the retinal detachment model 
(Verardo et al., 2008), and reduced pathological neovascularization in oxygen-induced 
retinopathy (Lundkvist et al., 2004). We and others also demonstrated that in GFAP–/–
Vim–/– mice, grafts can better integrate into the host retina (Kinouchi et al., 2003), 
differentiation of transplanted neural stem cells into neurons and astrocytes is enhanced 
(Widestrand et al., 2007). In addition, we found that in GFAP–/–Vim–/–mice, hippocampal 
neurogenesis is increased in naïve mice (Wilhelmsson et al., 2012), after neonatal 
hypoxic-ischemic injury (Jarlestedt et al., 2010), or after neurotrauma (Wilhelmsson et 
al., 2012). Thus, in a variety of injury models, the benefits of reactive gliosis in the acute 
stage of CNS injury is balanced against restricted regenerative potential at the later stage, 
and hence modulation of reactive gliosis targeting the intermediate filament system might 
lead to enhanced recovery after CNS injury. 
 
1.2.3 Phosphorylation of intermediate filaments 
The structure of intermediate filaments is dynamic, and the highly-controlled network 
reorganization by assembly and disassembly of intermediate filament proteins is essential 
for the cell motility, cell division and other cellular functions. (Herrmann and Aebi, 1998; 
Herrmann et al., 2007; Inagaki et al., 1996; Ivaska et al., 2007; Omary et al., 2006). The 
intermediate filament disassembly, which is regulated by phosphorylation of 
serine/threonine residues in the amino-terminal head domain of intermediate filament 
proteins (Inagaki et al., 1996; Sihag et al., 2007), was reported to be essential for the 
efficient separation of the two daughter cells during mitosis (Goto et al., 2003; Kawajiri 
et al., 2003; Yamaguchi et al., 2005; Yasui et al., 1998; Yasui et al., 2001). Some of the 
key phosphorylation sites and the protein kinases involved have already been identified, 
as described before (Chou et al., 1990; Goto et al., 1998; Goto et al., 2003; Goto and 
Inagaki, 2007; Inada et al., 1999; Kawajiri et al., 2003; Kosako et al., 1997; Nishizawa et 
al., 1991; Tsujimura et al., 1994; Yamaguchi et al., 2005).  
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Phosphovimentin-deficient mice (VIMSA/SA mice), i.e. mice expressing vimentin in which 
all the serine sites that are phosporylated during mitosis were substituted by alanine 
residues, show cytokinetic failures in fibroblasts and lens epithelial cells resulting in 
aneuploidy, chromosomal instability, and increased expression of cell senescence 
markers (Matsuyama et al., 2013). VIMSA/SA mice exhibit some signs of pre-mature aging, 
including cataract development in lens, delayed skin wound healing, and subcutaneous 
fat loss in old age (Matsuyama et al., 2013; Tanaka et al., 2015). 
 
1.3 Mammalian adult neurogenesis 
1.3.1 The neurogenic niches in the adult mammalian brain 
Decades ago it was firmly believed that the adult mammalian brain was an organ without 
any neurogenesis, and this belief had not been challenged until 1960's (Altman, 1962). 
After decades of studies, it is now well established that adult mammalian neurogenesis 
exists throughout life, and is restricted to two brain niches: the subgranular zone (SGZ) 
of the dentate gyrus in the hippocampus and the subventricular zone (SVZ) of the lateral 
ventricle (Cameron et al., 1993; Cameron and McKay, 2001; Conover and Notti, 2008; 
Doetsch et al., 1999; Eriksson et al., 1998; Ernst and Frisen, 2015; Kirschenbaum et al., 
1999; Spalding et al., 2013; Wang et al., 2011). In the adult human brain, neural 
progenitor cells were also reported in the striatum (Ernst et al., 2014).  
 
In rodents, it was demonstrated that newly born neurons in the SVZ migrate along the 
rostral migratory stream into the olfactory bulb where they replace the interneurons 
throughout life (Angot et al., 2008; Kirschenbaum et al., 1999). Newly born neurons in 
the SGZ of the hippocampal dentate gyrus are capable of integrating into existing 
hippocampal neuronal networks but remain within the hippocampus (Gage, 2000; 
Kempermann et al., 2004). The rate of neurogenesis is affected by activities such as 
learning, exercise, exposure to environmental enrichment, stress and alcohol (Crews et 
al., 2004; Gould and Tanapat, 1999; Gould et al., 1999; Kempermann et al., 1997; van 
Praag et al., 1999). Neurogenesis in the dentate gyrus of the hippocampus regulates 
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formation of newly acquired memories as well as forgetting through hippocampal circuit 
remodeling (Akers et al., 2014; Chung et al., 2015).    
 
1.3.2 The neurogenic niche provides neurogenesis-permissive environment 
Transplantation studies of neural progenitor cells into various regions of the adult CNS 
showed that neuronal differentiation of the transplanted neural progenitor cells only 
occurs in the two adult neurogenic niches (Emsley et al., 2005; Goh et al., 2003; 
Shihabuddin et al., 2000; Suhonen et al., 1996). Only astrocytes isolated from neurogenic 
niche had the neuronegesis-permissive properties (Jiao and Chen, 2008; Song et al., 
2002). These findings point to the cellular environment as a key modulator for 
neurogenesis in the adult CNS.  
 
Extensive studies have been done to investigate the molecular mechanisms underlying 
astrocyte-induced neurogenesis, and several signaling pathways have been identified. For 
example, astrocytes enhance proliferation and differentiation of adult neural progenitor 
cells through increased insulin-like growth factor (IGF) signaling by decreased 
expression of insulin-like growth factor binding protein-6 (IGFBP-6) (Barkho et al., 
2006). Wnt3 was shown to be over-expressed in adult hippocampal astrocytes and was 
proposed to lead to increased neurogenesis (Lie et al., 2005). Sonic hedgehog (SHH) was 
reported to be expressed by SGZ astrocytes and stimulate neural progenitor cell 
proliferation (Jiao and Chen, 2008). Our laboratory previously demonstrated that the 
astrocyte intermediate filament system is important for Notch signaling from astrocytes 
to neural progenitor cells, and astrocytes devoid of intermediate filaments support 
increased differentiation of neural progenitors into neurons, astrocytes or 
oligodendrocytes in the hippocampus of adult mouse brain (Lebkuechner et al., 2015; 
Widestrand et al., 2007; Wilhelmsson et al., 2012). 
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1.3.3 Neurogenic regions outside the well-established neurogenic niches 
Whether there are neurogenic regions other than the well-established neurogenic niches 
is still under debate. During the recent decades, in vitro neurosphere studies indicated 
that it was possible to isolate multipotent neural progenitor cells from live human brain 
tissue obtained from surgical resections (Arsenijevic et al., 2001; Nunes et al., 2003). 
However, studies on adult human brains, by means of 5-bromo-2′-deoxyuridine (BrdU) 
labeling of proliferating cells, determination of the 14C isotope incorporated into DNA 
during cell proliferation, as well as magnetic resonance spectroscopy, did not reveal any 
evidence of neurogenesis in human cortical regions (Eriksson et al., 1998; Manganas et 
al., 2007; Spalding et al., 2005). Interestingly, in rodents some reactive/de-differentiated 
astrocytes which are found in areas with reactive gliosis after e.g. traumatic brain injury 
or stroke, seem to exhibit properties of neural progenitor cells (Buffo et al., 2008; 
Shimada et al., 2012). These findings widened our view of adult neurogenesis.  
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2 AIMS OF THE STUDIES 
I. To study whether the activation of astrocytes in human epilepsy leads to de-
differentiation of these cells, and whether some reactive astrocytes would acquire 
properties of neural progenitor cells (Paper I). To establish a protocol for obtaining viable 
single cells from freshly isolated human brain tissue (Paper II). 
 
II. To study whether the vimentin phosphorylation deficit in VIMSA/SA mice alters 
astrocyte morphology, proliferative capacity and cell motility, and whether the 
phosphovimentin-deficient astrocyte niche affects neuronal differentiation of neural 
progenitor cells in vitro or neurogenesis in vivo (Paper III).  
 
III. To study the drug candidates that could potentially decrease the expression of GFAP 
and other astrocyte intermediate filament proteins, and to assess their effect on 
neurosupportive properties and resilience of astrocytes to oxygen and glucose deprivation 
(OGD; Paper IV). 
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3 MATERIAL AND METHODS 
3.1 Human research specimens and tissue dissociation (Paper I and 
II) 
Human cerebral cortex tissue was obtained from 19 patients operated for 
pharmacologically intractable epilepsy (2.5-45 years old, 10 females, 9 males; Paper I). 
Tumor tissue was collected from a grade IV astrocytoma (49 years old male patient); 
tumor and tumor penumbra tissue was collected from a grade III oligodendroglioma (63 
years old male patient; paper II). Brain surgery took place at Sahlgrenska University 
Hospital, Gothenburg, Sweden. During the surgery, the resected tissue was divided into 
a research specimen and a specimen that was used for histopathological diagnosis. 
Research specimens were collected and immediately transferred into cold Hybernate A 
medium (Invitrogen) for transportation to the cell culture facility. Research specimens 
were collected in accordance with the ethical guidelines of the Sahlgrenska University 
Hospital and the approval was obtained from the Regional ethical review board in 
Gothenburg (Dnr 179-08). 
 
The brain tissue was dissociated using MACS brain tumor dissociation T kit (Miltenyi 
Biotech) according to manufacturer’s protocol. The resulting single cell suspension was 
purified with MACS myelin removal microbeads (Miltenyi Biotech) to remove the 
myelin debris. To obtain GLAST-positive astrocytes for cell culture, the isolated cells 
were sorted using MACS anti-GLAST (ACSA-1) microbeads (Miltenyi Biotech; Paper 
I). To obtain single cells for mRNA expression profiling, the isolated cells were sorted 
by a FACS Aria II (Becton-Dickinson) with single cell sorting function into separate 
wells of a 96-well plate (Paper II).  
 
3.2 Mice (Paper III and IV) 
To study the impact of vimentin phosphorylation to astrocyte cell morphology and 
functions (Paper III), we used phosphovimentin-deficient mice (VIMSA/SA mice), i.e. mice 
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expressing vimentin in which all the serine sites that are phosporylated during mitosis 
were substituted by alanine residues (Matsuyama et al., 2013; Tanaka et al., 2015), and 
their respective wild-type controls on a C57BL/6 genetic background. VIMSA/SA mice are 
viable, and show phenotypes as described before (Matsuyama et al., 2013; Tanaka et al., 
2015). 
 
To study the effect of drug candidates on neurosupportive properties and resilience of 
astrocytes to oxygen and glucose deprivation (OGD) in vitro (Paper IV), we used wild-
type mice and mice carrying a null mutation in the GFAP and vimentin genes [(GFAP–/–
Vim–/–); (Colucci-Guyon et al., 1994; Eliasson et al., 1999; Pekny et al., 1995; Pekny et 
al., 1999)] on a mixed C57BL/6-129Sv-129Ola genetic background. GFAP–/–Vim–/– mice 
are viable, and show phenotypes as described before (Pekny and Pekna, 2014).  
 
All mice were housed in standard cages in a barrier animal facility and had free access to 
food and water. All the experiments were conducted according to protocols approved by 
the Ethics Committee of the University of Gothenburg (Dnr. 247-2014). 
 
3.3 Cell culture and in vitro analysis 
3.3.1 Neurosphere culture (Paper I and III) 
The neurosphere in vitro assay was developed in 1990’s and it soon became a commonly 
used method to evaluate the two major neural stem cell properties: self-renewal and 
multipotency, i.e. ability to differentiate into neurons, astrocytes and oligodendrocytes 
(Brewer and Torricelli, 2007; Reynolds and Weiss, 1992). The neurosphere assay is 
based on the concept that neural stem cells could divide symmetrically and form free 
floating spherical clusters (neurospheres) in a serum-free culture medium, in the presence 
of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF).  
 
To assess the multipotency of the neurosphere cells, neurospheres or dissociated 
neurosphere cells were plated on poly-L-ornithine and laminin coated coverslips or 
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culture dishes, in presence of 0.1%-1% fetal calf serum (FCS) without growth factors. 
The differentiation was assessed by immunocytochemical detection of cell type specific 
markers (βIII tubulin and MAP2 for neurons, GFAP for astrocytes, and O4 for 
oligodendrocytes).       
                                                                                                                                                                                                                                                                                                                                                                                                                                               
3.3.2 Neurosphere cells and neurons co-cultured with astrocytes (Paper III 
and IV) 
In rodents, cortical neurogenesis completes at embryonic day 15, the onset of gliogenesis 
occurs after the onset of neurogenesis, with the peak of astrogenesis perinatally and the 
peak of oligodendrogenesis postnatally (Gotz and Huttner, 2005; Semple et al., 2013). 
Therefore, in our in vitro studies, mouse cortical neurons were prepared from E17.5 
mouse cortex to reduce astrocyte contamination, mouse cortical astrocytes were prepared 
from P0.5-2.5 mouse cortex, and multipotent neurosphere cells were prepared from P2.5-
3.5 mouse forebrain.  
 
To investigate the effect of astrocyte environment on neuronal differentiation (Paper III), 
neurosphere cells were plated on top of primary astrocytes. To distinguish the 
neurosphere cells and co-cultured astrocytes, 0.5 µM BrdU was added into the 
neurosphere culture medium 48 h prior to dissociation. The neuronal differentiation was 
assessed by quantification of βIII-tubulin labeled cells as a fraction of BrdU-positive cells. 
 
To investigate the astrocyte neurosupportive properties (Paper IV), neurons were plated 
on top of primary astrocytes. Astrocyte neurosupportive properties were assessed by 
counting the surviving neurons and measuring the neurite length.  
 
3.4 Bioactive3D – a novel three-dimensional cell culture system that allows to 
maintain some of the in vivo properties of astrocytes (Paper III) 
The traditional 2-dimensional (2D) cell cultures constitute a highly artificial and stressful 
environment, where astrocytes are forced to grow on a flat culture dish without the 3-
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dimensional (3D) support. Astrocytes in 2D cell cultures resemble reactive astrocytes, by 
exhibiting increased proliferation, upregulated expression of GFAP and vimentin, and re-
expressing nestin (Andreasson et al., 2016; Puschmann et al., 2013).  
 
We previously developed a novel 3D cell culture system (Bioactive3D) and demonstrated 
that Bioactive3D culture system allows the cultured astrocytes to maintain some in vivo-
like properties (Andreasson et al., 2016; Puschmann et al., 2013; Puschmann et al., 2014a; 
Puschmann et al., 2014b). Astrocytes cultured in Bioactive3D system retain aspects of 
their complex in vivo-like morphology (Fig 2), have minimal baseline reactivity and 
show reduced cell proliferation (Puschmann et al., 2013). Neurons cultured in 
Bioactive3D system extended their neurites to all dimensions and formed complex 
structures, and astrocyte contamination in the neuron cultures in the Bioactive3D system 
was minimized due to their reduced proliferation (Puschmann et al., 2014a).  
 
 
3.5 Assessment of cell proliferation and survival in the mouse hippocampus 
(Paper III) 
To detect a small population of dividing neural progenitor cells in the adult mouse brain, 
BrdU in vivo labeling is used. BrdU, a thymidine analogue, is incorporated into the 
replicating DNA of dividing cells. Immunohistochemical detection of BrdU-positive 
 
Fig 2. Astrocytes cultured in 2D and 
Bioactive3D show distinct morphology, 
adapted from (Andreasson et al., 2016) 
 
Primary astrocytes cultured in the Bioactive3D 
system, which is composed of polyurethane 
nanofibers coated with poly-L-ornithin and 
laminin, preserve some of the complex 
morphological and biochemical features of in 
vivo astrocytes that are normally lost upon 2D 
culture (compare the left and right panel). Space 
bar, 10 μm. The primary astrocytes were 
derived from mice expressing enhanced green 
fluorescein protein under the control of GFAP 
promoter (Andreasson et al., 2016; Pekny and 
Pekna, 2014; Puschmann et al., 2013). 
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cells in brain sections allows to visualize the neural progenitor cells and follow their 
survival and differentiation over time. For detection of all dividing cells in vivo, the dose 
of intraperitoneally administered BrdU ranges between 100-300 mg/kg, which is non-
toxic to rodents (Cameron and McKay, 2001; Wojtowicz and Kee, 2006). 
  
We administered BrdU intraperitoneally (300mg/kg) to label and follow the cell fate of 
newly born cells in the hippocampal dentate gyrus of adult VimSA/SA mice and their 
respective controls. Double labeling using anti-BrdU and anti-doublecortin (DCX) 
antibodies was applied to visualize and count the neuronal precursors and immature 
neurons. Double labeling using anti-BrdU and anti-NeuN was applied to visualize and 
count the surviving newly generated neurons.  
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4 RESULTS AND DISCUSSION 
4.1 Paper I and II 
In the adult human brain, neural progenitor cells are present in the subventricular zone 
(Curtis et al., 2007; Wang et al., 2011), the hippocampus (Eriksson et al., 1998; Spalding 
et al., 2013) and the striatum (Ernst et al., 2014). In rodents, reactive astrocytes were 
proposed to exhibit properties of neural progenitor cells (Buffo et al., 2008; Shimada et 
al., 2012). However, the origin of multipotent neural progenitor cells obtained from 
human brain cortical surgical resections (Arsenijevic et al., 2001; Kirschenbaum et al., 
1994; Nunes et al., 2003) is still under debate. In Paper I, we addressed the following 
questions: Can activation of astrocytes in epilepsy lead to de-differentiation of some of 
these cells? Do some astrocytes, when activated, de-differentiate into cells with neural 
progenitor cell properties capable of giving rise to all three cell types of the neurogenic 
lineage – i.e. neurons, astrocytes and oligodendrocytes? We hypothesized that some 
reactive astrocytes within the epileptic foci of patients with epilepsy have properties of 
neural progenitor cells. Within Paper II, we developed protocols for dissociating human 
brain tissue into single live cells.  
 
In Paper I, we assessed the capacity of cells dissociated from fresh cortical tissue from 
patients who underwent surgical treatment for pharmacologically intractable epilepsy to 
form neurospheres and the differentiation potential of the neurosphere cells. 
Neurospheres were generated from 57% of cases (8/14). Upon differentiation, the 
neurosphere cells gave rise to neurons, oligodendrocytes and astrocytes. Sorting of 
dissociated cells showed that only cells negative for astrocyte marker glutamate aspartate 
transporter (GLAST) formed neurospheres. The origin of these cells in the human 
epileptic cortex warrants further investigation. This finding is an important step in our 
understanding of the processes ongoing in the epileptic tissue and of the role of astrocytes 
in epilepsy. 
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4.2 Paper III 
It was previously reported that mutation of the serine sites that are phosporylated in 
vimentin during mitosis (VIMSA/SA) leads to cytokinetic failures in fibroblasts and lens 
epithelial cells in mice, resulting in chromosomal instability and increased expression of 
cell senescence markers (Matsuyama et al., 2013; Tanaka et al., 2015). In this study, we 
investigated morphology, proliferative capacity and cell motility of VIMSA/SA astrocytes, 
and their effect on the differentiation of neural progenitor cells. 
 
We found that VIMSA/SA astrocytes expressed lower levels of vimentin protein, but showed 
a well-developed intermediate filament network, exhibited normal cell morphology, 
proliferation, and motility in the in vitro wound closing assay. Thus, phosphorylation of 
vimentin during mitosis does not seem to play a role in the control of morphology, cell 
division and motility of astrocytes. This is in contrast to VIMSA/SA lens epithelial cells or 
fibroblasts that showed disrupted intermediate filament network and formation of 
unbreakable intermediate filament-bridges during mitosis. Vimentin is highly expressed 
in astrocytes, lens epithelial cells and fibroblasts. In astrocytes, vimentin forms 
intermediate filaments together with GFAP and nestin. Given that GFAP is highly 
expressed in postnatal astrocytes but not in lens epithelial cells or fibroblasts (Boyer et 
al., 1990; Matsuyama et al., 2013; Tanaka et al., 2015), it is possible that in VIMSA/SA 
astrocytes GFAP compensates for the relative lack of vimentin and/or affects the 
intermediate filament dynamics. We have already crossed the VIMSA/SA mice with GFAP–
/– mice, and will assess the role of vimentin phosphorylation in the absence of GFAP in 
astrocytes. 
 
Interestingly, we found a 2-4-fold increased neuronal differentiation of VIMSA/SA 
neurosphere cells, both in a standard 2D and in Bioactive3D cell culture systems, and 
determined that this effect was neurosphere cell autonomous, and not dependent on co-
cultured astrocytes. Using BrdU in vivo labeling to assess neural progenitor cell 
proliferation and differentiation in the hippocampus of adult mice, we found a modest 
increase (by 8 %) in the fraction of newly born and surviving neurons. It would be noted 
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that the neural sphere cells were isolated from the whole forebrain of P2.5-3.5 mouse 
pups, including the hippocampus and the subventricular zone, but we only assessed the 
newly born and surviving neurons in the adult mouse hippocampus. Therefore, it would 
be interesting to assess the neurosphere cells isolated from the adult mouse hippocampus. 
The prominent in vitro effect of VIMSA/SA mutation can also possibly be mitigated or 
masked in vivo by niche-related factors that remain to be identified. Even in Bioactive3D, 
a cell culture system closer to the in vivo situation, the increased neurogenesis from 
neurosphere cells was very robust and more prominent compared to the modest increase 
in hippocampal neurogenesis in VIMSA/SA mice. This result was conceivably due to the 
absence of other niche constituents such as endothelial cells and microglia in the in vitro 
system. Notch signaling, which regulates the neural stem cell proliferation and 
differentiation (Liu et al., 2010; Wilhelmsson et al., 2012), is worth further investigation. 
Interestingly, in the experiment assessing the number of surviving neurons 6 weeks 
following BrdU administration, we found that the increase in the fraction of surviving 
neurons in VIMSA/SA mice was due to a decrease in the size of the subpopulation of non-
neuronal BrdU-positive cells. It is essential to further identify that cell population in 
future studies. It will be also interesting to connect the difference of the in vivo phenotype 
to a behavioral correlation, such as learning and memory. Our preliminary data showed 
that VIMSA/SA mice had unimpaired short-term and long-term memory in the novel object 
recognition test, but other tests can be further applied. 
 
In conclusion, mutation of the serine sites phosphorylated in vimentin during mitosis has 
no or minimal effect on astrocytes, but leads to an increased neuronal differentiation of 
neural progenitor cells. The functional significance of this finding and the involvement 
of phosphovimentin in the functions of other cellular elements which express vimentin 
in the neurogenic niche, such as the endothelial cells and microglia, warrants further 
investigation. 
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4.3 Paper IV 
As modulation of reactive gliosis targeting the intermediate filament system might lead 
to enhanced recovery after CNS injury, we hypothesized that pharmacological 
modulation of the astrocyte nanofilament system improves survival of neurons when co-
cultured with astrocytes under standard conditions or when exposed to oxygen and 
glucose deprivation, an in vitro model of brain ischemia. Several drugs were reported to 
decrease GFAP expression in vitro and in vivo (Bargagna-Mohan et al., 2010; Cho et al., 
2010; Middeldorp et al., 2009). Clomipramine (8 µM) treatment of astrocyte cultures for 
10 days decreased the amount of GFAP by 50% (Cho et al., 2010). Epoxomicin, and 
other proteasome inhibitors, decreased GFAP mRNA and soluble protein levels in human 
astrocytoma U343 cells at doses ranging from 5 to 100 nM as well as GFAP protein levels 
in a rat model for induced astrogliosis (Middeldorp et al., 2009). In astrocyte cultures, 
withaferin A downregulated soluble vimentin and GFAP at 0.5 µM and systemic delivery 
of withaferin A down-regulated expression of both vimentin and GFAP in mouse retinas 
(Bargagna-Mohan et al., 2010). 
 
In this paper, we examined the effect of epoxomicin, clomipramine and withaferin A, 
three candidate drugs for targeting the astrocyte nanofilament system, on astrocyte 
resilience to ischemic stress in vitro, and astrocyte neurosupportive properties. 
Clomipramine decreased protein levels of GFAP, vimentin and nestin in astrocytes, and 
did not affect astrocyte resilience to oxidative stress. Both clomipramine and epoxomicin 
promoted the attachment and survival of neurons co-cultured with astrocytes under 
standard culture conditions. Moreover, epoxomicin increased neurosupportive properties 
of astrocytes after oxygen and glucose deprivation. Our data identify clomipramine and 
epoxomicin as potential candidates for astrocyte modulation to improve outcome after 
CNS injury. 
 
In summary, this study suggests that pharmacological modulation of the astrocyte 
intermediate filament system by epoxomicin and clomipramine can increase the 
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neurosupportive properties of astrocytes without compromising their ability to cope with 
ischemic stress.  
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5 CONCLUSIONS  
This thesis invested the role of astrocytes and the intermediate filaments in neural 
plasticity, neuroregeneration and neuroprotection. Specifically, we have found that 
 
1. Cells with neural progenitor cell properties exist in human epileptic tissue outside the 
two neurogenic niches, and they are not GLAST-positive astrocytes.  
 
2. Mutation of the serine sites phosphorylated in vimentin during mitosis in mice has no 
or minimal effect on astrocytes, but leads to an increased neuronal differentiation of 
neural progenitor cells both in vitro and in vivo. 
 
3. Both clomipramine and epoxomicin promote the survival of neurons co-cultured with 
astrocytes under standard culture conditions, and epoxomicin increases neurosupportive 
properties of astrocytes after oxygen and glucose deprivation. 
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
Astrocyter är en viktig celltyp i det centrala nervsystemet (CNS) och kontrollerar många 
neurologiska funktioner, som upptagning och återvinning av signalsubstanser, induktion 
och eliminering av kopplingar mellan hjärnans nervceller, samt styr blodförsörjningen 
till hjärnvävnaden. Vid skador och sjukdom i CNS, som neurotrauma, stroke, epilepsi 
och neurodegenerativa sjukdomar, aktiveras astrocyter, vilket också kallas reaktiv glios. 
Två viktiga kännetecken för reaktiv glios är förtjockning av astrocyternas utskott och 
uppreglering av de proteiner som utgör intermediära filament i astrocyter (också kallade 
nanofilament som utgör en del av cytoskelettet): glial fibrillary acidic protein (GFAP), 
vimentin, nestin och synemin. Under den akuta fasen av hjärnskada kan reaktiv glios 
begränsa skadan och skydda omgivande hjärnvävnad, men långvarig reaktiv glios kan 
hämma hjärnans plasticitet och utväxten av nervutskott. Att aktivera astrocyter vid den 
akuta fasen och att dämpa kronisk reaktiv glios därefter kan därför vara en potentiell 
terapeutisk strategi vid skador och sjukdom i CNS.  
 
Vår forskargrupp har utvecklat transgena möss som saknar GFAP och vimentin, och 
dessa möss saknar därmed nanofilament i astrocyter. Dessa möss uppvisar en dämpad 
reaktiv glios, och en ökad nybildning av neuroner i hippocampus, ett av de två områden 
i den hjärnan där neurala stamceller finns även i vuxen ålder.  
 
Det har föreslagits att reaktiva astrocyter vid hjärnskador kan också fungera som neurala 
stamceller utanför de delarna av hjärnan där neurala stamceller normalt finns hos vuxna. 
Det är därför mycket intressant att utröna om fenomenet förekommer hos människor. I 
delarbete I isolerade vi celler från kirurgiska resektioner av vävnad från epilepsipatienter 
(protokoll för isolation av celler från vävnaden utvecklades inom delarbete II), och 
studerade deras potential som neurala stamceller. Vi upptäckte att celler med 
stamcellspotential fanns i vävnaden även utanför de etablerade neurogena områdena hos 
patienter som opererades för epilepsi och att dessa celler inte var reaktiva astrocyter.  
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I delarbete III studerade vi betydelsen av fosforylering av vimentin, en viktig 
regleringprocess för proteins funktioner som nanofilament, genom att använda transgena 
möss med mutaterade fosforyleringställen (VimSA/SA möss) som gör att vimentin inte kan 
fosforyleras. Vi visade en ökad differentiering av stamceller till neuroner hos VimSA/SA 
neurala stamceller jämfört med normala neurala stamceller. Denna ökning var oberoende 
av om astrocyterna i stamcellernas omgivning var VimSA/SA eller från kontrollmöss.  
 
I delarbete IV utvärderade vi om farmakologisk reglering av nanofilament i astrocyter 
kan påverka astrocyters förmåga att stödja neuroners överlevnad och deras tillväxt av 
nervcellsutskott. Vi använde tre läkemedel som rapporterats att minska mängden GFAP 
i astrocyter och studerade deras effekt på astrocyters förmåga att stödja neuroners 
överlevnad och tillväxt under normala förhållanden och i en modell av hjärnischemi med 
minskade nivåer av syre och glukos. Två av de tre testade läkemedlen stödde 
överlevnaden av neuroner samodlades med astrocyter. Studien föreslår dessa två 
läkemedel som potentiella kandidater att använda för att modulera astrocyter och reaktiv 
glios för att förbättra återhämtning efter CNS-skador. 
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